Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 09-Jul-2021
No. of pages: 105
Inquire Before Buying

Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.

Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.

Market Analysis and Insights: Global Metastatic Colorectal Cancer Treatment Market

The global Metastatic Colorectal Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Colorectal Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Colorectal Cancer Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Colorectal Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Colorectal Cancer Treatment market.

Global Metastatic Colorectal Cancer Treatment Scope and Market Size

Metastatic Colorectal Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Colorectal Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Surgery

- Chemotherapy

Segment by Application

- Hospitals

- Clinics

- Cancer Research Centers

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Sanofi

- Roche

- Eli Lilly

- Pfizer

- Novartis

- Amgen

- Taiho Oncology

- Genentech

- EMD Serono

- Suzhou Zelgen Biopharmaceuticals

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Colorectal Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Colorectal Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Colorectal Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Colorectal Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Colorectal Cancer Treatment Industry Dynamic
2.3.1 Metastatic Colorectal Cancer Treatment Market Trends
2.3.2 Metastatic Colorectal Cancer Treatment Market Drivers
2.3.3 Metastatic Colorectal Cancer Treatment Market Challenges
2.3.4 Metastatic Colorectal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Colorectal Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Colorectal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Colorectal Cancer Treatment Revenue
3.4 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Colorectal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Treatment Revenue in 2020
3.5 Metastatic Colorectal Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Colorectal Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Colorectal Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Metastatic Colorectal Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Colorectal Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Colorectal Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Colorectal Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Colorectal Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Colorectal Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Metastatic Colorectal Cancer Treatment Introduction
11.1.4 Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Metastatic Colorectal Cancer Treatment Introduction
11.2.4 Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Introduction
11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Metastatic Colorectal Cancer Treatment Introduction
11.4.4 Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Metastatic Colorectal Cancer Treatment Introduction
11.5.4 Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Metastatic Colorectal Cancer Treatment Introduction
11.6.4 Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Taiho Oncology
11.7.1 Taiho Oncology Company Details
11.7.2 Taiho Oncology Business Overview
11.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Introduction
11.7.4 Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.7.5 Taiho Oncology Recent Development
11.8 Genentech
11.8.1 Genentech Company Details
11.8.2 Genentech Business Overview
11.8.3 Genentech Metastatic Colorectal Cancer Treatment Introduction
11.8.4 Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.8.5 Genentech Recent Development
11.9 EMD Serono
11.9.1 EMD Serono Company Details
11.9.2 EMD Serono Business Overview
11.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Introduction
11.9.4 EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.9.5 EMD Serono Recent Development
11.10 Suzhou Zelgen Biopharmaceuticals
11.10.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Introduction
11.10.4 Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021)
11.10.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Metastatic Colorectal Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Global Metastatic Colorectal Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Metastatic Colorectal Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Colorectal Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2016-2021)
Table 8. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Table 10. Metastatic Colorectal Cancer Treatment Market Trends
Table 11. Metastatic Colorectal Cancer Treatment Market Drivers
Table 12. Metastatic Colorectal Cancer Treatment Market Challenges
Table 13. Metastatic Colorectal Cancer Treatment Market Restraints
Table 14. Global Metastatic Colorectal Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Metastatic Colorectal Cancer Treatment Market Share by Players (2016-2021)
Table 16. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2020)
Table 17. Ranking of Global Top Metastatic Colorectal Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastatic Colorectal Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Metastatic Colorectal Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Metastatic Colorectal Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Metastatic Colorectal Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Metastatic Colorectal Cancer Treatment Product
Table 64. Sanofi Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Metastatic Colorectal Cancer Treatment Product
Table 69. Roche Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Metastatic Colorectal Cancer Treatment Product
Table 74. Eli Lilly Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Metastatic Colorectal Cancer Treatment Product
Table 79. Pfizer Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Metastatic Colorectal Cancer Treatment Product
Table 84. Novartis Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Metastatic Colorectal Cancer Treatment Product
Table 89. Amgen Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Taiho Oncology Company Details
Table 92. Taiho Oncology Business Overview
Table 93. Taiho Oncology Metastatic Colorectal Cancer Treatment Product
Table 94. Taiho Oncology Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Taiho Oncology Recent Development
Table 96. Genentech Company Details
Table 97. Genentech Business Overview
Table 98. Genentech Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 99. Genentech Recent Development
Table 100. EMD Serono Company Details
Table 101. EMD Serono Business Overview
Table 102. EMD Serono Metastatic Colorectal Cancer Treatment Product
Table 103. EMD Serono Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 104. EMD Serono Recent Development
Table 105. Suzhou Zelgen Biopharmaceuticals Company Details
Table 106. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 107. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product
Table 108. Suzhou Zelgen Biopharmaceuticals Revenue in Metastatic Colorectal Cancer Treatment Business (2016-2021) & (US$ Million)
Table 109. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Colorectal Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Global Metastatic Colorectal Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Metastatic Colorectal Cancer Treatment Report Years Considered
Figure 9. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Metastatic Colorectal Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Metastatic Colorectal Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Metastatic Colorectal Cancer Treatment Market Share by Regions (2022-2027)
Figure 13. Global Metastatic Colorectal Cancer Treatment Market Share by Players in 2020
Figure 14. Global Top Metastatic Colorectal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Colorectal Cancer Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Treatment Revenue in 2020
Figure 16. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Metastatic Colorectal Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 20. North America Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 21. North America Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 22. United States Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 26. Europe Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 27. Europe Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 28. Germany Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Metastatic Colorectal Cancer Treatment Market Share by Region (2016-2027)
Figure 38. China Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Metastatic Colorectal Cancer Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Metastatic Colorectal Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 63. Taiho Oncology Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 64. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 65. EMD Serono Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 66. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs